Advertisement
Skip to Content

Bruker Corp BRKR Stock Quote

| Rating as of

NASDAQ: BRKR

Last close prices updated as of Jan 26, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 72.34
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Mid Growth
  • Day Range 71.18  –  73.23
  • Year Range 48.42  –  74.94
  • Market Cap 10.5738 Bil
  • Volume / Avg 529,210.0 /  643,480.9
  • Price / Sales 4.35
  • Price / Book 11.36
  • Forward Div Yield 0.29%
  • Trailing Div Yield 0.28%

Morningstar‘s Stock Analysis BRKR

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BRKR

Company Profile BRKR

Business Description

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.

Contact
40 Manning Road
Billerica, MA, 01821
Industry Medical Devices
Employees 7,765

FAQs for Bruker Corp Stock

Yes. BRKR has a forward dividend yield of 0.29%. See BRKR’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BRKR’s market cap is 10.57 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BRKR’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BRKR’s price/sales is 4.35.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

BRKR’s price/forward earnings is 27.03.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

BRKR’s price/book is 11.36.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See BRKR’s valuation ratios compared to the Market Index.

BRKR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BRKR’s historical performance against its industry peers and the overall market.